title: Session 4: overall integrated viral clearance and adventitious agents strategy.
authors.affiliation: Paul-Ehrlich-Institut; and Johannes.Bluemel@pei.de omar.tounekti@hc-sc.gc.ca.
authors.forename: Johannes
authors.initials: J
authors.lastname: Blümel
authors.affiliation: Health Canada Johannes.Bluemel@pei.de omar.tounekti@hc-sc.gc.ca.
authors.forename: Omar
authors.initials: O
authors.lastname: Tounekti
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000737:chemistry / Q000494:pharmacology*; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D003902:Detergents / Q000737:chemistry / Q000494:pharmacology; D006801:Humans; D019562:Viral Load / Q000187:drug effects* / Q000502:physiology
chemical_list: D000998:Antiviral Agents; D003902:Detergents